In the news: Chinese capital market turmoil discussed, GSK scientists steal trade secrets and Shanghai's VC compensation plan under fire

This week China's stocks and capital outflows were analyzed, ex-Glaxo employees were charged with cancer drug data theft, investors criticized a local venture capital investment incentive and a probe into new-energy auto subsidies fraud began